3
Views
4
CrossRef citations to date
0
Altmetric
Original papers

The Outcome of 48 Renal Transplantations Immunosuppressed with Cyclosporine-A as Monotherapy

, , , &
Pages 65-67 | Received 02 Dec 1985, Published online: 15 Feb 2010

REFERENCES

  • Canadian Multicenter Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J M 1983; 309: 809–810.
  • European Multicenter Trial Group. Cyclosporine in cadaveric renal transplantation, one year follow-up of a multicenter trial. Lancet 1983; 2: 986–989.
  • Hakala TR, Starzl TE, Rosenthal JT, Shaw B, Iwatsuki S. Cadaveric renal transplantation with cyclosporine-A and steroids. Transplant Proc 1983; 15: 465–470.
  • Holt DW, Marsden JT, Rogerson ME, Reid KE, Bewick M. The value of cyclosporine measurements following renal transplantation. Br J Clin Pharmacol 1985; 19: 548.
  • Kjaer H, Hansen HE, Olsen S. The predictive value of percutaneous biopsies from human renal allografts with early impaired function. Clin Nephrol 1980; 13: 58–63.
  • Klintmalm G, Sawe J, Ringden O, Bahr v C, Magnusson A. Cyclosporine plasma levels in renal transplant patients. Transplantation 1985; 39: 132–137.
  • Merion RM, White DJG, Thiru S, Evans DB, Calne RY. Cyclosporine: Five years experiences in cadaveric renal transplantation. N Engl J M 1984; 310: 148–154.
  • Najarian JS, Ferguson RM, Sutherland DER, Rynasiewcz JJ, Simmons RL. A prospective trial of the efficacy of cyclosporine in renal transplantation at the University of Minnesota. Transplant Proc 1983; 15: 438–441.
  • Rittembourg J, Mattei MF, Cabrol A et al. Renal function and blood pressure in heart transplant recipients treated with cyclosporine. J Heart Transplant 1985; 4: 147.
  • Taube DH, Williams DG, Hartley B et al. Differentiation between allograft rejection and cyclosporine nephrotoxicity in renal transplant recipients. Lancet 1985; 2: 171–174.
  • White DJG, McNaughton D, Calne RY. Is monitoring of cyclosporine-A serum levels of clinical value?. Transplant Proc 1983; XV: 454–456.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.